Promising results for metastatic pancreatic cancer drug
Israeli specialist leads multinational research study on new drug regimen for those with BRCA mutations, published in New England Journal of Medicine.
JUNE 3, 2019, 10:04 AM
Abigail Klein Leichman is a writer and associate editor at ISRAEL21c. Prior to moving to Israel in 2007, she was a specialty writer and copy editor at a major daily newspaper in New Jersey and has freelanced for a variety of newspapers and periodicals since 1984.
.png)
No hay comentarios:
Publicar un comentario